An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06939647 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2026-04-29
Summary
The purpose of this study is to provide continued access to TPIP for participants who have successfully completed the open-label extension (OLE) studies of INS1009-203 for PAH or INS1009-212 for PH-ILD.
Conditions
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension, Interstitial Lung Disease
Interventions
- DRUG
-
Treprostinil Palmitil
Treprostinil Palmitil Inhalation Powder
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
NCT05176951 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
NCT05147805 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NCT03012646 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD
NCT04691154 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
NCT07333183 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
NCT05564637 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Treprostinil for PAH: Open-label Extension
NCT01557660 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
NCT03496623 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
NCT03464864 ·Status: COMPLETED ·Phase: PHASE1
-
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
NCT00705133 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
NCT03794583 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
NCT02725372 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension
NCT07177703 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
NCT04062565 ·Status: RECRUITING ·Phase: PHASE3
-
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH
NCT03556020 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
NCT00703339 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
NCT00147199 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
NCT02633293 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Tezosentan in Patients With Pulmonary Arterial Hypertension
NCT01094067 ·Status: TERMINATED ·Phase: PHASE2
-
Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen
NCT03135860 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
NCT02603068 ·Status: WITHDRAWN ·Phase: PHASE2
-
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
NCT01457781 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension
NCT03835676 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
NCT03315507 ·Status: COMPLETED ·Phase: PHASE1